Skip to content

Women's Refusal to Participate in a Randomized Trial Involving First-trimester Screening for Pre-eclampsia: Factors Associated With Refusal and Reasons for Acceptance and Refusal

Women's Refusal to Participate in a Randomized Trial Involving First-trimester Screening for Pre-eclampsia: Factors Associated With Refusal and Reasons for Acceptance and Refusal

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06322771
Acronym
RANSPRE-refus
Enrollment
472
Registered
2024-03-21
Start date
2024-04-11
Completion date
2024-10-31
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Related

Keywords

Refusal, Clinical trial, Factors, Reasons, Pregnancy, Pre-eclampsia

Brief summary

The main objective is to assess whether there are factors associated with women's refusal to participate in a randomized clinical trial involving first-trimester screening for pre-eclampsia. The secondary objective is to qualitatively evaluate the reasons for acceptance and refusal to participate.

Detailed description

1. Determine the acceptance/refusal rate among all women identified, eligible and offered RCT. 2. Comparison of demographic characteristics between the two groups * Group 1: women accepting to participate in RCT * Group 2: women refusing to participate in RCT 3. Assessment of motivations for acceptance (based on questionnaire given to women who agree to participate) 4. Evaluation of reasons for refusal to participate - obstacles (based on the questionnaire given to women who refuse to participate).

Interventions

BEHAVIORALQuestionnaire

Questionnaire about acceptance

Sponsors

URC-CIC Paris Descartes Necker Cochin
CollaboratorOTHER
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum

Inclusion criteria

: Inclusion criteria are the same as for the RANSPRE trial. Any pregnant woman is eligible if: * monofetal pregnancy * between 11 and 14 weeks * legal age * health insurance coverage

Exclusion criteria

: Inclusion criteria are the same as for the RANSPRE trial. A history of pre-eclampsia in a previous pregnancy and a contraindication to aspirin are non-inclusion criteria.

Design outcomes

Primary

MeasureTime frameDescription
Factors associated with women's refusalDay 1The primary objective is to assess whether there are factors associated with women's refusal to participate in the RANSPRE randomized clinical trial.

Secondary

MeasureTime frameDescription
Number of acceptationsDay 1
Number of refusalsDay 1
Demographic characteristicsDay 1
Questionnaire acceptanceDay 1Evaluation of motivations linked to acceptance (based on the questionnaire given to women who agree to participate) The secondary objective is to qualitatively assess the reasons for acceptance of participation.
Questionnaire refusalDay 1Evaluation of the reasons for refusing to participate - obstacles (based on the questionnaire given to women who refuse to participate). The secondary objective is to qualitatively assess the reasons for refusal of participation.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026